FR2755976B1 - Nouveaux complexes d'acides nucleiques et de polymere substitue par des residus entrainant la destabilisation des membranes cellulaires - Google Patents

Nouveaux complexes d'acides nucleiques et de polymere substitue par des residus entrainant la destabilisation des membranes cellulaires

Info

Publication number
FR2755976B1
FR2755976B1 FR9613990A FR9613990A FR2755976B1 FR 2755976 B1 FR2755976 B1 FR 2755976B1 FR 9613990 A FR9613990 A FR 9613990A FR 9613990 A FR9613990 A FR 9613990A FR 2755976 B1 FR2755976 B1 FR 2755976B1
Authority
FR
France
Prior art keywords
destabilization
free
groups
cell membranes
nucleic acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9613990A
Other languages
English (en)
French (fr)
Other versions
FR2755976A1 (fr
Inventor
Patrick Midoux
Michel Monsigny
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IDM Immuno Designed Molecules
Original Assignee
IDM Immuno Designed Molecules
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9613990A priority Critical patent/FR2755976B1/fr
Application filed by IDM Immuno Designed Molecules filed Critical IDM Immuno Designed Molecules
Priority to DE69730348T priority patent/DE69730348T2/de
Priority to JP52325798A priority patent/JP2001504344A/ja
Priority to IL128912A priority patent/IL128912A/en
Priority to EP97945903A priority patent/EP0946744B1/fr
Priority to US09/297,519 priority patent/US6372499B1/en
Priority to AU51239/98A priority patent/AU742818B2/en
Priority to CA002267833A priority patent/CA2267833A1/fr
Priority to AT97945903T priority patent/ATE274066T1/de
Priority to ES97945903T priority patent/ES2225992T3/es
Priority to PCT/FR1997/002022 priority patent/WO1998022610A1/fr
Publication of FR2755976A1 publication Critical patent/FR2755976A1/fr
Application granted granted Critical
Publication of FR2755976B1 publication Critical patent/FR2755976B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/645—Polycationic or polyanionic oligopeptides, polypeptides or polyamino acids, e.g. polylysine, polyarginine, polyglutamic acid or peptide TAT
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
FR9613990A 1996-11-15 1996-11-15 Nouveaux complexes d'acides nucleiques et de polymere substitue par des residus entrainant la destabilisation des membranes cellulaires Expired - Fee Related FR2755976B1 (fr)

Priority Applications (11)

Application Number Priority Date Filing Date Title
FR9613990A FR2755976B1 (fr) 1996-11-15 1996-11-15 Nouveaux complexes d'acides nucleiques et de polymere substitue par des residus entrainant la destabilisation des membranes cellulaires
AT97945903T ATE274066T1 (de) 1996-11-15 1997-11-10 Neue polymerische komplexe für die transfektion von nukleinsaüren, mit resten für destabilisierung der zellmembranen
IL128912A IL128912A (en) 1996-11-15 1997-11-10 Complexes of nucleic acids with polymers substituted by residues which enable transfection of cells
EP97945903A EP0946744B1 (fr) 1996-11-15 1997-11-10 Nouveaux complexes polymeriques pour la transfection d'acides nucleiques, avec des residus destabilisant des membranes cellulaires
US09/297,519 US6372499B1 (en) 1996-11-15 1997-11-10 Polymeric complexes for the transfection of nucleic acids, with residues causing the destabilisation of cell membranes
AU51239/98A AU742818B2 (en) 1996-11-15 1997-11-10 Novel polymeric complexes for the transfection of nucleic acids, with residues causing the destabilisation of cell membranes
DE69730348T DE69730348T2 (de) 1996-11-15 1997-11-10 Neue polymerische komplexe für die transfektion von nukleinsaüren, mit resten für destabilisierung der zellmembranen
JP52325798A JP2001504344A (ja) 1996-11-15 1997-11-10 核酸のトランスフェクションのための、細胞膜の脱安定化を引き起こす残基を有する新規なポリマー性複合体
ES97945903T ES2225992T3 (es) 1996-11-15 1997-11-10 Nuevos complejos polimericos para la transfeccion de acidos nucleicos, con residuos que desestabilizan unas membranas celulares.
PCT/FR1997/002022 WO1998022610A1 (fr) 1996-11-15 1997-11-10 Nouveaux complexes polymeriques pour la transfection d'acides nucleiques, avec des residus destabilisant des membranes cellulaires
CA002267833A CA2267833A1 (fr) 1996-11-15 1997-11-10 Nouveaux complexes polymeriques pour la transfection d'acides nucleiques, avec des residus destabilisant des membranes cellulaires

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9613990A FR2755976B1 (fr) 1996-11-15 1996-11-15 Nouveaux complexes d'acides nucleiques et de polymere substitue par des residus entrainant la destabilisation des membranes cellulaires

Publications (2)

Publication Number Publication Date
FR2755976A1 FR2755976A1 (fr) 1998-05-22
FR2755976B1 true FR2755976B1 (fr) 1999-01-15

Family

ID=9497684

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9613990A Expired - Fee Related FR2755976B1 (fr) 1996-11-15 1996-11-15 Nouveaux complexes d'acides nucleiques et de polymere substitue par des residus entrainant la destabilisation des membranes cellulaires

Country Status (11)

Country Link
US (1) US6372499B1 (enExample)
EP (1) EP0946744B1 (enExample)
JP (1) JP2001504344A (enExample)
AT (1) ATE274066T1 (enExample)
AU (1) AU742818B2 (enExample)
CA (1) CA2267833A1 (enExample)
DE (1) DE69730348T2 (enExample)
ES (1) ES2225992T3 (enExample)
FR (1) FR2755976B1 (enExample)
IL (1) IL128912A (enExample)
WO (1) WO1998022610A1 (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6919076B1 (en) 1998-01-20 2005-07-19 Pericor Science, Inc. Conjugates of agents and transglutaminase substrate linking molecules
CA2348823A1 (en) * 1998-12-02 2000-06-08 I.D.M. Immuno-Designed Molecules New oligomeric conjugates liable to transfer biological molecules into cells
AU7352200A (en) * 1999-09-01 2001-03-26 Regents Of The University Of California, The Novel natriuretic peptide receptors, interacting compounds and methods of regulating proliferation and/or survival of neurons
US7070807B2 (en) 1999-12-29 2006-07-04 Mixson A James Branched histidine copolymers and methods for using same
EP1242052A4 (en) * 1999-12-29 2003-07-02 A James Mixson HISTIDIN COPOLYMER AND METHODS OF USE THEREOF
CA2797652C (en) * 2000-07-21 2016-03-08 Revance Therapeutics, Inc. Multi-component biological transport systems
FR2812658B1 (fr) * 2000-08-01 2005-04-15 De Bruno Vandiere Procede d'analyse d'acides nucleiques
US7465708B2 (en) 2002-11-25 2008-12-16 Mixson A James Branched cationic copolymers and methods for antimicrobial use
AU2005251676B2 (en) 2004-03-03 2011-09-29 Revance Therapeutics, Inc. Compositions and methods for topical diagnostic and therapeutic transport
US9211248B2 (en) 2004-03-03 2015-12-15 Revance Therapeutics, Inc. Compositions and methods for topical application and transdermal delivery of botulinum toxins
US7740861B2 (en) * 2004-06-16 2010-06-22 University Of Massachusetts Drug delivery product and methods
US20060040879A1 (en) * 2004-08-21 2006-02-23 Kosak Kenneth M Chloroquine coupled nucleic acids and methods for their synthesis
CN101052383B (zh) 2004-09-17 2013-01-30 马萨诸塞大学 用于溶酶体酶缺乏症的组合物和其用途
US20060094104A1 (en) * 2004-10-29 2006-05-04 Leopold Grillberger Animal protein-free media for cultivation of cells
US20060211004A1 (en) 2005-02-15 2006-09-21 Ilsley Diane D Methods and compositions for determining non-specific cytotoxicity of a transfection agent
BRPI0608249A2 (pt) 2005-03-03 2009-12-08 Revance Therapeutics Inc formulação, método para aplicação tópica e kit para distribuição transdérmica de toxina botulìnica
WO2007050643A2 (en) * 2005-10-24 2007-05-03 University Of Massachusetts Compositions and their uses for gene therapy of bone conditions
JP2011517279A (ja) * 2007-10-29 2011-06-02 ユニバーシティ オブ マサチューセッツ 核酸（ｓｉＲＮＡ）送達用の酵母細胞壁粒子（ＹＣＷＰ）多層状ナノ粒子
FR2928373B1 (fr) * 2008-03-05 2010-12-31 Centre Nat Rech Scient Polymere derive de la polyethylenimine lineaire pour le transfert de gene.
WO2010008582A2 (en) 2008-07-18 2010-01-21 Rxi Pharmaceuticals Corporation Phagocytic cell drug delivery system
CN108165548B (zh) 2008-09-22 2022-10-14 菲奥医药公司 减小大小的自递送RNAi化合物
WO2010078536A1 (en) 2009-01-05 2010-07-08 Rxi Pharmaceuticals Corporation Inhibition of pcsk9 through rnai
WO2012115772A2 (en) 2011-02-25 2012-08-30 Medtronic, Inc. Therapy for kidney disease and/or heart failure
EP2750697A4 (en) 2011-09-02 2015-03-25 Medtronic Inc CHIMERIC NATRIURETIC PEPTIDE COMPOSITIONS AND METHOD FOR THE PRODUCTION THEREOF
US9162191B2 (en) * 2012-11-15 2015-10-20 Board Of Trustees Of The University Of Alabama Imidazole-containing polymer membranes and methods of use
CN102949729B (zh) * 2012-11-20 2014-06-18 中国科学院宁波材料技术与工程研究所 主动靶向型小干扰核糖核酸输送载体及其制备方法
AR122446A1 (es) * 2020-04-29 2022-09-14 Medimmune Llc Composiciones y métodos para suministrar agentes farmacéuticamente activos
WO2022189361A1 (en) * 2021-03-08 2022-09-15 Universiteit Gent Conjugates including multiple saccharidic chains on a linear protein and uses in mammals feed

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1316990A (en) * 1970-09-17 1973-05-16 Roche Products Ltd Imidazolyl derivatives
US5166320A (en) * 1987-04-22 1992-11-24 University Of Connecticut Carrier system and method for the introduction of genes into mammalian cells
JP2827287B2 (ja) * 1988-07-05 1998-11-25 武田薬品工業株式会社 水溶性薬物含有徐放型マイクロカプセル
US5354844A (en) * 1989-03-16 1994-10-11 Boehringer Ingelheim International Gmbh Protein-polycation conjugates
ES2090049T3 (es) * 1989-03-16 1996-10-16 Boehringer Ingelheim Int Unidades geneticas para la inhibicion de la funcion de arn.
WO1992011037A2 (en) * 1990-12-19 1992-07-09 Advanced Magnetics Inc. Targeting of therapeutic agents using polysaccharides
DE4104186A1 (de) * 1991-02-12 1992-08-13 Genentech Inc Neue, ueber endozytose in hoehere eukaryotische zellen aufnehmbare, nukleinsaeure enthaltende komplexe
WO1993009176A2 (en) * 1991-10-29 1993-05-13 Clover Consolidated, Limited Crosslinkable polysaccharides, polycations and lipids useful for encapsulation and drug release
DK0636028T3 (da) * 1992-04-03 2004-07-12 Univ California Selvorganiserende polynucleotidleveringssystem omfattende et amfipatisk kationisk peptid
FR2719316B1 (fr) * 1994-04-28 1996-05-31 Idm Nouveaux complexes d'acide nucléique et de polymère, leur procédé de préparation et leur utilisation pour la transfection de cellules.
US5733762A (en) * 1994-04-28 1998-03-31 I.D.M. Immuno-Designed Molecules Complexes of nucleic acid and polymer, their process of preparation and their use for the transfection of cells
US6030941A (en) * 1996-05-01 2000-02-29 Avi Biopharma, Inc. Polymer composition for delivering substances in living organisms

Also Published As

Publication number Publication date
ES2225992T3 (es) 2005-03-16
ATE274066T1 (de) 2004-09-15
EP0946744A1 (fr) 1999-10-06
AU742818B2 (en) 2002-01-10
EP0946744B1 (fr) 2004-08-18
DE69730348T2 (de) 2005-09-01
DE69730348D1 (de) 2004-09-23
FR2755976A1 (fr) 1998-05-22
US6372499B1 (en) 2002-04-16
JP2001504344A (ja) 2001-04-03
WO1998022610A1 (fr) 1998-05-28
CA2267833A1 (fr) 1998-05-28
IL128912A0 (en) 2000-02-17
IL128912A (en) 2006-06-11
AU5123998A (en) 1998-06-10

Similar Documents

Publication Publication Date Title
FR2755976B1 (fr) Nouveaux complexes d'acides nucleiques et de polymere substitue par des residus entrainant la destabilisation des membranes cellulaires
Pantano et al. Enzyme-modified carbon-fiber microelectrodes with millisecond response times
Okada Molecular design and syntheses of glycopolymers
RU2223966C2 (ru) Зонд для анализа нуклеиновых кислот
DE69528363D1 (de) Neue nukleinsaure-polymer komplexe, verfahren zur deren herstellung und verwendung zur transfektion von zellen
US7195925B2 (en) Polymer having an upper critical solution temperature
Coggins et al. Use of dimethyl suberimidate and novel periodate-cleavable bis (imido esters) to study the quaternary structure of the pyruvate dehydrogenase multienzyme complex of Escherichia coli
Hedwig et al. Thermodynamic properties of peptide solutions 9. Partial molar isentropic pressure coefficients in aqueous solutions of sequence isomeric tripeptides with a single-CH3 side-chain
BR9811675A (pt) Genes isolados para proteìna da membrana de célula dentrìtica
WO2012118780A2 (en) Preparation of peptide mixtures by protease catalysis designed to provide useful biological and physical properties
Winnick et al. Biosynthesis of gramicidin S I. General characteristics of the process in growing cultures of Bacillus brevis
ATE260337T1 (de) Neue oligomere konjugate zum transfer biologischer moleküle in zellen
ATE389718T1 (de) Isolierung von nukleinsäuren unter verwendung eines polykationischen polymers als fällungsmittel
KR940007056A (ko) 단백질과 이 단백질을 코우드하는 dna 및 이 단백질의 제조방법
ATE192739T1 (de) Schwachbasische polymerisierbare monomere und daraus hergestellte polymere
WO1999055718A3 (en) Solution phase biopolymer synthesis
Chang et al. Methylation of ribosomal proteins in vitro
Habuchi et al. Sea urchin egg receptor for sperm: the oligosaccharide chains stabilize sperm binding
Kakuchi et al. Lymphocyte activation effect of (1→ 6)-2, 5-anhydro-d-glucitol and it derivatives with 3, 4-di-O-methyl and sulfate groups
ES2353466T3 (es) Nuevo procedimiento de preparación de copolímeros tipo peine hidrosolubles.
Hon et al. Permeation Characteristics of Poly (Hydroxypropyl Methacrylate) membrane having Tertiary Amine Moiety
Katchalski Novel Techniques for the Synthesis of Linear and Cyclic Peptides
DE69006601D1 (de) Amidcopolymere mit niedrigem molekulargewicht.
Castelletti et al. Characterization of polymeric buffers for operating membrane‐trapped enzyme reactors in an electric field
Stanek et al. Synthesis and characterization of copolymers of N, N-dimethylacryl amide and methyl methacrylate with 2-vinyl-4, 4'-dimethylazlactone.

Legal Events

Date Code Title Description
ST Notification of lapse